Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04166877 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Magnesium Infusion for Pain Management in Critically Ill Trauma Patients

StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Re-verified, no change to tracked fieldsv9
  2. Primary and study completion dates: Dec 31, 2025 to Dec 31, 2026v8
  3. Primary and study completion dates: Dec 31, 2024 to Dec 31, 2025v7
  4. Re-verified, no change to tracked fieldsv6
  5. Primary completion date: Dec 31, 2022 to Dec 31, 2024
    • Study completion date: Dec 1, 2023 to Dec 31, 2024
    v5
Show 3 earlier versionsHide 3 earlier versions
  1. Primary completion date: Jul 31, 2022 to Dec 31, 2022v4
  2. Primary completion date: Dec 1, 2020 to Jul 31, 2022
    • Study completion date: Dec 1, 2021 to Dec 1, 2023
    v3
  3. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Nov 25, 2019 to Dec 7, 2019
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Magnesium is a naturally occurring mineral that is important for your body and brain. Magnesium sulfate (study drug) is a medication containing magnesium that is commonly used to improve low blood levels of magnesium. Magnesium sulfate has also proven to be successful in managing pain before and after surgery. However, this drug has primarily been used for pain control in patients undergoing surgery. Patients in the ICU with injuries also need good pain control. Using magnesium may assist in decreasing narcotic (pain reliever) requirements and provide another non-narcotic drug for pain control. The purpose of this study is to test the effectiveness of continuous, intravenous (into or within a vein using a needle) administration of magnesium sulfate for pain control in trauma patients admitted to the adult Intensive Care Unit. This will be compared to intravenous normal saline (salt solution).
Trial Details
NCT Number NCT04166877
Lead Sponsor University of California, Davis
Conditions
(from sponsor)		 Trauma, Acute Pain
Related terms Acute Pain, Wounds and Injuries
Enrollment 156 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov